5Brouwers AH,Buijs WC,Oosterwijk E,et al.Targeting of metastatic renal cell carcinoma with the chimeric monoclonal antibody G250 labeled with ^131I and ^111I:an intrapatient comparison.Clin Cancer Res,2003,9:3953-3960. 被引量：1
6Potter CPS,Harris AL.Diagnostic,prognostic and therapeutic implications of carbonic anhydrases in cancer.Br J Cancer,2003,89:2-7. 被引量：1
7Uemura H,Nakagawa Y,Yoshida K,et al.MN/CA Ⅸ/G250 as a potential target for immunotherapy of renal cell carcinomas.Br J Cancer,1999,81:741-746. 被引量：1
8Bui M,Seligson D,Han K,et al.Carbonic anhydrase Ⅸ is an independent predictor of survival in advanced renal clear cell carcinoma:implications for prognosis and therapy.Clin Cancer Res,2003,9:802-811. 被引量：1
9Vissers J,De Vries IJ,Schreurs MW,et al.The renal cell carcinomaassociated antigen G250 encodes a human leukocyte antigen (HLA)A2.1-restricted epitope recognized by cytoxic T lymphocytes.Cancer Res,1999,59:5554-5559. 被引量：1
10Steffens MG,Boerman OC,Oosterwijk-Wakka JC,et al.Targeting of renal cell carcinoma with iodine-131I labeled chimerc monoclonal antibody G250.J Clin Oncol,1997,15:1529-1537. 被引量：1
